De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?

Table 2 Case reports in the literatures on de novo proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts

Case	Age at diagnosis	Gender	Onset time (mo)	Type of IgG deposits	C1q deposition	Native kidney disease	Pattern of glomerular injury	Monoclonal gammopathy	Ref.
1	24	M	43	IgG3κ	N/A	T1DM	MPGN	None	Albawardi et al[64] (2011)
2	68	F	156	IgG1κ	N/A	PKD	MPGN	None	Albawardi et al[64] (2011)
3	38	F	72	IgG3κ	1+	T1DM	MesGN or EC	N/A	Hussain et al[72] (2017)
4	61	F	98	IgG3κ	C1q	MPGN	EC	None	Al-Rabadi et al[73] (2015)
5	40	F	132	IgG3κ	N/A	MPGN	MPGN	None	Al-Rabadi et al[73] (2015)
6	46	M	49	IgG1κ	1+	FSGS	MesGN	N/A	Li et al[77] (2017)
7	69	M	6	IgG3κ	1+	Obesity (FSGS?)	MPGN	N/A	Merhi et al[75] (2017)

EPGN: Endocapillary proliferative glomerulonephritis; FSGS: Focal segmental glomerulosclerosis; MesGN: Mesangioproliferaitve glomerulonephritis; MPGN: Membranoproliferative glomerulonephritis; N/A: Not available; PGNMID: Proliferative glomerulonephritis with monoclonal IgG deposits; PKD: Polycystic kidney disease; T1DM: Type 1 diabetes mellitus; EC: Endocapillary proliferative; M: Male; F: Female.